NPAS2 and Parkinson disease: NPAS2 promoter significantly hypomethylated in PD patients compared to healthy controls•Both groups had some CRY1, insignificant BMAL1 methylation•No detectable methylation in PER1, PER2, CRY2, and CLOCK promoters